| 000 | 01739 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250511175750.0 | ||
| 264 | 0 | _c19920127 | |
| 008 | 199201s 0 0 eng d | ||
| 022 | _a0732-183X | ||
| 024 | 7 |
_a10.1200/JCO.1992.10.1.16 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFukuoka, M | |
| 245 | 0 | 0 |
_aA phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cJan 1992 |
||
| 300 |
_a16-20 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 |
_aCamptothecin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aDiarrhea _xchemically induced |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aIrinotecan |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aNiitani, H | |
| 700 | 1 | _aSuzuki, A | |
| 700 | 1 | _aMotomiya, M | |
| 700 | 1 | _aHasegawa, K | |
| 700 | 1 | _aNishiwaki, Y | |
| 700 | 1 | _aKuriyama, T | |
| 700 | 1 | _aAriyoshi, Y | |
| 700 | 1 | _aNegoro, S | |
| 700 | 1 | _aMasuda, N | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 10 _gno. 1 _gp. 16-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.1992.10.1.16 _zAvailable from publisher's website |
| 999 |
_c1315903 _d1315903 |
||